CA
RETA

Corriente Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Corriente Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
2021
Q2 		$10.1M Buy
2021
Q1 		– Sell
2020
Q4 		$64.9M Buy
2020
Q3 		$29.2M Buy
2020
Q2 		$23M Sell
2020
Q1 		$27.4M Sell
2019
Q4 		$39.3M Buy